Medicale Corp.
MCLE
$0.03
-$0.01-16.13%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -56.94% | -38.57% | -24.34% | -12.36% | 4.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -56.94% | -38.57% | -24.34% | -12.36% | 4.78% |
| Operating Income | 56.94% | 38.57% | 24.34% | 12.36% | -4.78% |
| Income Before Tax | 46.50% | 29.33% | 14.75% | 2.24% | -15.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 46.50% | 29.33% | 14.75% | 2.24% | -15.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.50% | 29.33% | 14.75% | 2.24% | -15.80% |
| EBIT | 56.94% | 38.57% | 24.34% | 12.36% | -4.78% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 47.37% | 31.00% | 15.79% | 2.20% | -17.28% |
| Normalized Basic EPS | 45.76% | 27.87% | 12.07% | 0.00% | -18.00% |
| EPS Diluted | 47.37% | 31.00% | 15.79% | 2.20% | -17.28% |
| Normalized Diluted EPS | 45.76% | 27.87% | 12.07% | 0.00% | -18.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |